Medical Advisors


Chi Van Dang, M.D., Ph.D.

Chairman of the Medical Advisory Board

Director of the Abramson Cancer Center of the University of Pennsylvania. Dr. Dang is considered by many to be the world’s leading authority on cancer metabolism and serves as Rafael’s Chairman of the Scientific and Medical Advisory Boards. Dr. Dang is also serving on Rafael’s Board of Directors.


Pancreatic Cancer Advisors:

Philip A. Philip, M.D., Ph.D., FRCP

Professor of Oncology and Pharmacology, Leader, GI and Neuroendocrine Oncology, Vice President of Medical Affairs, Karmanos Cancer Center, Wayne State University, Detroit, MI

Jordan D. Berlin, M.D.

Co-Leader, Gastrointestinal Cancer Research Program, Professor of Medicine (Hematology/Oncology), Director, Phase I Program, Medical Oncologist, Vanderbilt-Ingram Cancer Center

J. Randolph Hecht, M.D.

Director, Gastrointestinal Cancer Program, Professor of Clinical Medicine, David Geffen School of Medicine at UCLA

Heloisa P. Soares, M.D., Ph.D.

Section leader, HPB cancers and NETs clinical program, University of New Mexico Comprehensive Cancer Center

Josep Tabernero M.D., Ph.D.

Head, Medical Oncology Dept, the Vall d´Hebron University Hospital. Director, Vall d´Hebron Institute of Oncology (VHIO), Barcelona Area, Spain

Eric Van Cutsem, M.D., Ph.D.

Medical Doctor and Professor of Medicine (Digestive Oncology) at University Hospital Gasthuisberg/Leuven, Belgium


Acute Myeloid Leukemia Advisors:

Jorge Cortes, M.D.

Deputy Chair and Professor of Medicine in the Department of Leukemia at The University of Texas MD Anderson Cancer Center

Bayard L. Powell, M.D.

Section Chief, Hematology & Oncology, Associate Director for Clinical Research, Comprehensive Cancer Center, Professor, Hematology & Oncology, Wake Forest Baptist Medical Center

Mikkael Sekeres, M.D.

Director, Leukemia Program, Vice-chair for Clinical Research, Cleveland Clinic’s Taussig Cancer Institute

Richard M. Stone, M.D.

Professor of Medicine, Harvard Medical School; Associate Physician, Medicine, Brigham And Women’s Hospital; Director, Adult Leukemia Program, Dana-Farber Cancer Institute


Lymphoma Advisors:

Craig H. Moskowitz, M.D.

Physician in Chief, Oncology Service Line, Sylvester Comprehensive Cancer Center Professor, Department of Medicine

Ariela Noy, M.D.

Attending Physician and Member: Hematology Divistion/Lymphoma Service; Memorial Sloan-Kettering Cancer Center; Chair of the Lymphoma Working Group for the AIDS Malignancy Consortium

Steven I. Park, M.D.

Division Chief, Hematology and Oncology, Levine Cancer Institute, CHS-Northeast; Director of Investigational Therapeutics in Hematologic Malignancies, Levine Cancer Institute/Carolinas HealthCare System; Associate Professor of Medicine, University of North Carolina, Chapel Hill

Medical Advisors


Chi Van Dang, M.D., Ph.D.

Chairman of the Medical Advisory Board

Director of the Abramson Cancer Center of the University of Pennsylvania. Dr. Dang is considered by many to be the world’s leading authority on cancer metabolism and serves as Rafael’s Chairman of the Scientific and Medical Advisory Boards. Dr. Dang is also serving on Rafael’s Board of Directors.


Pancreatic Cancer Advisors:

Philip A. Philip, M.D., Ph.D., FRCP

Professor of Oncology and Pharmacology, Leader, GI and Neuroendocrine Oncology, Vice President of Medical Affairs, Karmanos Cancer Center, Wayne State University, Detroit, MI

Jordan D. Berlin, M.D.

Co-Leader, Gastrointestinal Cancer Research Program, Professor of Medicine (Hematology/Oncology), Director, Phase I Program, Medical Oncologist, Vanderbilt-Ingram Cancer Center

J. Randolph Hecht, M.D.

Director, Gastrointestinal Cancer Program, Professor of Clinical Medicine, David Geffen School of Medicine at UCLA

Heloisa P. Soares, M.D., Ph.D.

Section leader, HPB cancers and NETs clinical program, University of New Mexico Comprehensive Cancer Center

Josep Tabernero M.D., Ph.D.

Head, Medical Oncology Dept, the Vall d´Hebron University Hospital. Director, Vall d´Hebron Institute of Oncology (VHIO), Barcelona Area, Spain

Eric Van Cutsem, M.D., Ph.D.

Medical Doctor and Professor of Medicine (Digestive Oncology) at University Hospital Gasthuisberg/Leuven, Belgium


Acute Myeloid Leukemia Advisors:

Jorge Cortes, M.D.

Deputy Chair and Professor of Medicine in the Department of Leukemia at The University of Texas MD Anderson Cancer Center

Bayard L. Powell, M.D.

Section Chief, Hematology & Oncology, Associate Director for Clinical Research, Comprehensive Cancer Center, Professor, Hematology & Oncology, Wake Forest Baptist Medical Center

Mikkael Sekeres, M.D.

Director, Leukemia Program, Vice-chair for Clinical Research, Cleveland Clinic’s Taussig Cancer Institute

Richard M. Stone, M.D.

Professor of Medicine, Harvard Medical School; Associate Physician, Medicine, Brigham And Women’s Hospital; Director, Adult Leukemia Program, Dana-Farber Cancer Institute


Lymphoma Advisors:

Craig H. Moskowitz, M.D.

Physician in Chief, Oncology Service Line, Sylvester Comprehensive Cancer Center Professor, Department of Medicine

Ariela Noy, M.D.

Attending Physician and Member: Hematology Divistion/Lymphoma Service; Memorial Sloan-Kettering Cancer Center; Chair of the Lymphoma Working Group for the AIDS Malignancy Consortium

Steven I. Park, M.D.

Division Chief, Hematology and Oncology, Levine Cancer Institute, CHS-Northeast; Director of Investigational Therapeutics in Hematologic Malignancies, Levine Cancer Institute/Carolinas HealthCare System; Associate Professor of Medicine, University of North Carolina, Chapel Hill